BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 19139173)

  • 1. Natural micropolymorphism in human leukocyte antigens provides a basis for genetic control of antigen recognition.
    Archbold JK; Macdonald WA; Gras S; Ely LK; Miles JJ; Bell MJ; Brennan RM; Beddoe T; Wilce MC; Clements CS; Purcell AW; McCluskey J; Burrows SR; Rossjohn J
    J Exp Med; 2009 Jan; 206(1):209-19. PubMed ID: 19139173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TCR alpha genes direct MHC restriction in the potent human T cell response to a class I-bound viral epitope.
    Miles JJ; Borg NA; Brennan RM; Tynan FE; Kjer-Nielsen L; Silins SL; Bell MJ; Burrows JM; McCluskey J; Rossjohn J; Burrows SR
    J Immunol; 2006 Nov; 177(10):6804-14. PubMed ID: 17082594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of human leukocyte antigen (HLA) micropolymorphism on ligand specificity within the HLA-B*41 allotypic family.
    Bade-Döding C; Theodossis A; Gras S; Kjer-Nielsen L; Eiz-Vesper B; Seltsam A; Huyton T; Rossjohn J; McCluskey J; Blasczyk R
    Haematologica; 2011 Jan; 96(1):110-8. PubMed ID: 20934997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cis-trans isomerization of the Epstein-Barr virus determinant peptide EENLLDFVRF after the DM1 TCR recognition of the HLA-B*4405/peptide complex.
    Stavrakoudis A
    FEBS Lett; 2011 Feb; 585(3):485-91. PubMed ID: 21167154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hierarchy of Epstein-Barr virus-specific cytotoxic T-cell responses in individuals carrying different subtypes of an HLA allele: implications for epitope-based antiviral vaccines.
    Khanna R; Burrows SR; Neisig A; Neefjes J; Moss DJ; Silins SL
    J Virol; 1997 Oct; 71(10):7429-35. PubMed ID: 9311821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic T cell recognition of allelic variants of HLA B35 bound to an Epstein-Barr virus epitope: influence of peptide conformation and TCR-peptide interaction.
    Khanna R; Silins SL; Weng Z; Gatchell D; Burrows SR; Cooper L
    Eur J Immunol; 1999 May; 29(5):1587-97. PubMed ID: 10359113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunogenicity of a viral cytotoxic T cell epitope is controlled by its MHC-bound conformation.
    Tynan FE; Elhassen D; Purcell AW; Burrows JM; Borg NA; Miles JJ; Williamson NA; Green KJ; Tellam J; Kjer-Nielsen L; McCluskey J; Rossjohn J; Burrows SR
    J Exp Med; 2005 Nov; 202(9):1249-60. PubMed ID: 16275762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of HLA-B micropolymorphism outside primary peptide anchor pockets on the CTL response to CMV.
    Burrows JM; Wynn KK; Tynan FE; Archbold J; Miles JJ; Bell MJ; Brennan RM; Walker S; McCluskey J; Rossjohn J; Khanna R; Burrows SR
    Eur J Immunol; 2007 Apr; 37(4):946-53. PubMed ID: 17357107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity.
    Burrows SR; Silins SL; Khanna R; Burrows JM; Rischmueller M; McCluskey J; Moss DJ
    Eur J Immunol; 1997 Jul; 27(7):1726-36. PubMed ID: 9247584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDR3α drives selection of the immunodominant Epstein Barr virus (EBV) BRLF1-specific CD8 T cell receptor repertoire in primary infection.
    Kamga L; Gil A; Song I; Brody R; Ghersi D; Aslan N; Stern LJ; Selin LK; Luzuriaga K
    PLoS Pathog; 2019 Nov; 15(11):e1008122. PubMed ID: 31765434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for clonal diversity of the human T-cell response to a dominant influenza virus epitope.
    Yang X; Chen G; Weng NP; Mariuzza RA
    J Biol Chem; 2017 Nov; 292(45):18618-18627. PubMed ID: 28931605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A molecular basis for the interplay between T cells, viral mutants, and human leukocyte antigen micropolymorphism.
    Liu YC; Chen Z; Neller MA; Miles JJ; Purcell AW; McCluskey J; Burrows SR; Rossjohn J; Gras S
    J Biol Chem; 2014 Jun; 289(24):16688-98. PubMed ID: 24759101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allelic polymorphism in the T cell receptor and its impact on immune responses.
    Gras S; Chen Z; Miles JJ; Liu YC; Bell MJ; Sullivan LC; Kjer-Nielsen L; Brennan RM; Burrows JM; Neller MA; Khanna R; Purcell AW; Brooks AG; McCluskey J; Rossjohn J; Burrows SR
    J Exp Med; 2010 Jul; 207(7):1555-67. PubMed ID: 20566715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I-bound peptide.
    Tynan FE; Burrows SR; Buckle AM; Clements CS; Borg NA; Miles JJ; Beddoe T; Whisstock JC; Wilce MC; Silins SL; Burrows JM; Kjer-Nielsen L; Kostenko L; Purcell AW; McCluskey J; Rossjohn J
    Nat Immunol; 2005 Nov; 6(11):1114-22. PubMed ID: 16186824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell allorecognition via molecular mimicry.
    Macdonald WA; Chen Z; Gras S; Archbold JK; Tynan FE; Clements CS; Bharadwaj M; Kjer-Nielsen L; Saunders PM; Wilce MC; Crawford F; Stadinsky B; Jackson D; Brooks AG; Purcell AW; Kappler JW; Burrows SR; Rossjohn J; McCluskey J
    Immunity; 2009 Dec; 31(6):897-908. PubMed ID: 20064448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the recognition by CTL of peptides presented by the HLA-B*4402 and the HLA-B*4403 molecules which differ by a single amino acid.
    Herman J; Jongeneel V; Kuznetsov D; Coulie PG
    Tissue Antigens; 1999 Feb; 53(2):111-21. PubMed ID: 10090611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis for ineffective T-cell responses to MHC anchor residue-improved "heteroclitic" peptides.
    Madura F; Rizkallah PJ; Holland CJ; Fuller A; Bulek A; Godkin AJ; Schauenburg AJ; Cole DK; Sewell AK
    Eur J Immunol; 2015 Feb; 45(2):584-91. PubMed ID: 25471691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single T cell receptor-mediated recognition of an identical HIV-derived peptide presented by multiple HLA class I molecules.
    Ueno T; Tomiyama H; Takiguchi M
    J Immunol; 2002 Nov; 169(9):4961-9. PubMed ID: 12391209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen.
    Burrows SR; Silins SL; Moss DJ; Khanna R; Misko IS; Argaet VP
    J Exp Med; 1995 Dec; 182(6):1703-15. PubMed ID: 7500015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural features underlying T-cell receptor sensitivity to concealed MHC class I micropolymorphisms.
    Stewart-Jones GB; Simpson P; van der Merwe PA; Easterbrook P; McMichael AJ; Rowland-Jones SL; Jones EY; Gillespie GM
    Proc Natl Acad Sci U S A; 2012 Dec; 109(50):E3483-92. PubMed ID: 23161907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.